Satralizumab in Aneurysmal Subarachnoid Hemorrhage

Summary

In this study, satralizumab will be administered to see whether satralizumab is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst brain aneurysm.

Timeline

Start

2024-06

Primary completion

2024-06-24

Completion

2024-06-24

Outcome

Outcome not reported

Stopped: “Lost support from the drug manufacturer”

Drugs

Indications